World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
54331
World Ranking
7522
National Ranking
3924

Mitchell P. Fink publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mitchell P. Fink sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 455 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mitchell P. Fink D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mitchell P. Fink sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 102 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mitchell P. Fink was a researcher affiliated with the University of California, Los Angeles, based in the United States. Their academic work focused primarily on the field of Medicine, with a specific concentration in Epidemiology. The main topic of their research involved the management of urinary tract infections.

Throughout their career, they contributed to the following research areas:

  • Urinary Tract Infections Management

Fink's publication record includes work in recognized scientific venues. Their recent published paper is:

  • "Urinary Tract Infection", 2023, published in American Academy of PediatricsItasca, IL eBooks

The scholar collaborated frequently with other researchers, including:

  • S Pelzl

Their research outputs were primarily disseminated through the following publication venue:

  • American Academy of PediatricsItasca, IL eBooks

Mitchell P. Fink's work contributed to the scientific understanding of urinary tract infections from an epidemiological perspective. The research reflected a focus on practical management strategies within the broader medical discipline.

Best Publications

  • 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

    Mitchell M. Levy;Mitchell P. Fink;John C. Marshall;Edward Abraham

  • Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

    Ziegler Ej;Fisher Cj;Sprung Cl;Straube Rc

  • The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States.

    Howard L. Corwin;Andrew Gettinger;Ronald G. Pearl;Mitchell P. Fink

  • Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

    Fisher Cj;Dhainaut Jf;Opal Sm;Pribble Jp

  • Reversing established sepsis with antagonists of endogenous high-mobility group box 1

    Huan Yang;Mahendar Ochani;Jianhua Li;Xiaoling Qiang

  • The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion

    Allan Tsung;Rohit Sahai;Hiroyuki Tanaka;Atsunori Nakao

  • Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies: A consensus statement

    G. D. Campbell;M. S. Niederman;W. A. Broughton;D. E. Craven

  • Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study.

    John A. Kellum;Lan Kong;Mitchell P. Fink;Lisa A. Weissfeld

  • Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation

    Luis Ulloa;Mahendar Ochani;Huan Yang;Mahira Tanovic

  • Laboratory models of sepsis and septic shock

    Mitchell P. Fink;Stephen O. Heard

  • Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

    Mitchell P. Fink;David R. Snydman;Michael S. Niederman;Kenneth V. Leeper Jr.

  • Hormonal responses to graded surgical stress.

    Bart Chernow;Bart Chernow;H. Richard Alexander;Robert C. Smallridge;W. Raleigh Thompson;W. Raleigh Thompson

  • Efficacy of Recombinant Human Erythropoietin in Critically Ill Patients: A Randomized Controlled Trial

    Howard L. Corwin;Andrew Gettinger;Ronald G. Pearl;Mitchell P. Fink

  • Structural basis for the proinflammatory cytokine activity of high mobility group box 1.

    Jianhua Li;Riikka Kokkola;Siamak Tabibzadeh;Runkuan Yang

  • Bench-to-bedside review: Cytopathic hypoxia

    Mitchell P Fink

  • HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice

    Penny L. Sappington;Runkuan Yang;Huan Yang;Kevin J. Tracey

  • Validation of tonometric measurement of gut intramural pH during endotoxemia and mesenteric occlusion in pigs.

    J. B. Antonsson;C. C. Boyle;K. L. Kruithoff;H. L. Wang

  • Cytopathic Hypoxia: Mitochondrial Dysfunction as Mechanism Contributing to Organ Dysfunction in Sepsis

    Mitchell P. Fink

  • Gastrointestinal mucosal injury in experimental models of shock, trauma, and sepsis.

    Mitchell P. Fink

  • Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats

    Naoki Unno;Hailong Wang;Michael J. Menconi;Stefaan H. A. J. Tytgat

Frequent Co-Authors

Timothy R. Billiar
Timothy R. Billiar University of Pittsburgh
Yoram Vodovotz
Yoram Vodovotz University of Pittsburgh
Jean Louis Vincent
Jean Louis Vincent Université Libre de Bruxelles
Kevin J. Tracey
Kevin J. Tracey Feinstein Institute for Medical Research
Peter Wipf
Peter Wipf University of Pittsburgh
Huan Yang
Huan Yang Feinstein Institute for Medical Research
John A. Kellum
John A. Kellum University of Pittsburgh
Valerian E. Kagan
Valerian E. Kagan University of Pittsburgh
Edward Abraham
Edward Abraham Dragonfly Data Science (New Zealand)
Deborah J. Cook
Deborah J. Cook McMaster University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can open up diverse career pathways in healthcare, particularly for those aiming to study Medicine or related fields in the USA. Many students are drawn to accelerated programs that help fast-track their education and entry into the workforce. For example, pursuing the shortest msn to dnp program lets nursing professionals efficiently progress from a Master of Science in Nursing to a Doctor of Nursing Practice, often in less time than traditional routes.

Flexibility is also an important factor. Accredited dnp online programs offer the ability to balance work and study, making them attractive to working nurses seeking advanced roles. For those starting their nursing careers, a 9 month lpn program provides a quicker entry into patient care positions.

Specialization is another key consideration. In-demand programs like psych np online programs equip graduates with advanced skills focused on psychiatric and mental health care – a growing field with rewarding opportunities.

Best Scientists Citing Mitchell P. Fink

Recently Published Articles